AR040279A2 - COMPOSITIONS CONTAINING SERTRALINE SALT - Google Patents
COMPOSITIONS CONTAINING SERTRALINE SALTInfo
- Publication number
- AR040279A2 AR040279A2 ARP030102179A ARP030102179A AR040279A2 AR 040279 A2 AR040279 A2 AR 040279A2 AR P030102179 A ARP030102179 A AR P030102179A AR P030102179 A ARP030102179 A AR P030102179A AR 040279 A2 AR040279 A2 AR 040279A2
- Authority
- AR
- Argentina
- Prior art keywords
- compositions containing
- sertraline salt
- containing sertraline
- cmax
- solubilizing agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Composición que contiene una forma de sal de sertralina altamente soluble que tiene una solubilidad mayor a 10mg/ml en agua pura y una cantidad de agente solublilizante suficiente para producir in vivo una Cmax y/o una AUC que es mayor en al menos un 10 % que la Cmax y/o la AUC producida por una composición comparativa de materia idéntica a la anterior pero sin incluir el mencionado agente solubilizante.Composition containing a form of highly soluble sertraline salt having a solubility greater than 10mg / ml in pure water and an amount of solubilizing agent sufficient to produce in vivo a Cmax and / or an AUC that is greater by at least 10% that the Cmax and / or the AUC produced by a comparative composition of matter identical to the previous one but not including the said solubilizing agent.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5141397P | 1997-07-01 | 1997-07-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR040279A2 true AR040279A2 (en) | 2005-03-23 |
Family
ID=21971159
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980103146A AR015917A1 (en) | 1997-07-01 | 1998-06-29 | COMPOSITIONS OF MATTER CONTAINING SERTRALIN AND PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA |
ARP030102180A AR040280A2 (en) | 1997-07-01 | 2003-06-19 | PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA |
ARP030102179A AR040279A2 (en) | 1997-07-01 | 2003-06-19 | COMPOSITIONS CONTAINING SERTRALINE SALT |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980103146A AR015917A1 (en) | 1997-07-01 | 1998-06-29 | COMPOSITIONS OF MATTER CONTAINING SERTRALIN AND PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA |
ARP030102180A AR040280A2 (en) | 1997-07-01 | 2003-06-19 | PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA |
Country Status (34)
Country | Link |
---|---|
EP (1) | EP0999829A1 (en) |
JP (1) | JP2000514100A (en) |
KR (1) | KR100366373B1 (en) |
CN (1) | CN1261794A (en) |
AP (1) | AP1192A (en) |
AR (3) | AR015917A1 (en) |
AU (1) | AU742535B2 (en) |
BG (1) | BG103918A (en) |
BR (1) | BR9810739A (en) |
CA (1) | CA2290974C (en) |
CO (1) | CO4940495A1 (en) |
DZ (1) | DZ2548A1 (en) |
EA (1) | EA002481B1 (en) |
HN (1) | HN1998000102A (en) |
HR (1) | HRP980377A2 (en) |
HU (1) | HUP0002236A3 (en) |
ID (1) | ID23429A (en) |
IL (1) | IL133076A (en) |
IS (1) | IS5260A (en) |
MA (1) | MA24587A1 (en) |
NO (1) | NO996520L (en) |
OA (1) | OA11243A (en) |
PA (1) | PA8454301A1 (en) |
PE (1) | PE97199A1 (en) |
PL (1) | PL337804A1 (en) |
SK (1) | SK181099A3 (en) |
TN (1) | TNSN98124A1 (en) |
TR (1) | TR199903297T2 (en) |
TW (1) | TW550087B (en) |
UA (1) | UA67741C2 (en) |
UY (1) | UY25071A1 (en) |
WO (1) | WO1999001120A1 (en) |
YU (1) | YU68299A (en) |
ZA (1) | ZA985708B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
YU43702A (en) | 1999-12-23 | 2004-11-25 | Pfizer Products Inc. | Pharmaceutical compositions providing enhanced drug concentrations |
US20030086972A1 (en) * | 2000-08-09 | 2003-05-08 | Appel Leah E. | Hydrogel-driven drug dosage form |
AU2001276608A1 (en) | 2000-08-30 | 2002-03-13 | Pfizer Products Inc. | Sustained release formulations for growth hormone secretagogues |
US20040191207A1 (en) * | 2003-03-31 | 2004-09-30 | Lipari John M. | Alpha-hydroxy acid ester drug delivery compositions and methods of use |
JP2010520897A (en) * | 2007-03-12 | 2010-06-17 | ディーエスエム アイピー アセッツ ビー.ブイ. | Cosmetic composition |
US20120289517A1 (en) * | 2009-12-29 | 2012-11-15 | Kowa Co., Ltd. | Solid pharmaceutical composition for oral administration |
CN102711763A (en) * | 2009-12-29 | 2012-10-03 | 兴和株式会社 | Pharmaceutical composition for oral administration |
CN109908354A (en) * | 2017-12-12 | 2019-06-21 | 万特制药(海南)有限公司 | Sertraline hydrochloride takes orally concentrate and its preparation process |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4803076A (en) * | 1986-09-04 | 1989-02-07 | Pfizer Inc. | Controlled release device for an active substance |
EP0415612B1 (en) * | 1989-08-30 | 1993-11-10 | Pfizer Inc. | Use of sertraline for the treatment of chemical dependencies |
ZA97976B (en) * | 1996-04-05 | 1997-08-18 | Alza Corp | Uniform drug delivery theraphy. |
-
1998
- 1998-06-15 JP JP11506774A patent/JP2000514100A/en active Pending
- 1998-06-15 SK SK1810-99A patent/SK181099A3/en unknown
- 1998-06-15 TR TR1999/03297T patent/TR199903297T2/en unknown
- 1998-06-15 CN CN98806763A patent/CN1261794A/en active Pending
- 1998-06-15 EA EA199900962A patent/EA002481B1/en unknown
- 1998-06-15 HU HU0002236A patent/HUP0002236A3/en unknown
- 1998-06-15 BR BR9810739-9A patent/BR9810739A/en not_active Application Discontinuation
- 1998-06-15 PL PL98337804A patent/PL337804A1/en unknown
- 1998-06-15 CA CA002290974A patent/CA2290974C/en not_active Expired - Fee Related
- 1998-06-15 WO PCT/IB1998/000933 patent/WO1999001120A1/en not_active Application Discontinuation
- 1998-06-15 AU AU75448/98A patent/AU742535B2/en not_active Ceased
- 1998-06-15 YU YU68299A patent/YU68299A/en unknown
- 1998-06-15 EP EP98923019A patent/EP0999829A1/en not_active Withdrawn
- 1998-06-15 KR KR10-1999-7011361A patent/KR100366373B1/en not_active IP Right Cessation
- 1998-06-15 UA UA99116391A patent/UA67741C2/en unknown
- 1998-06-15 IL IL13307698A patent/IL133076A/en not_active IP Right Cessation
- 1998-06-15 ID IDW991701A patent/ID23429A/en unknown
- 1998-06-25 AP APAP/P/1998/001280A patent/AP1192A/en active
- 1998-06-25 TW TW087110267A patent/TW550087B/en active
- 1998-06-26 PE PE1998000573A patent/PE97199A1/en not_active Application Discontinuation
- 1998-06-29 PA PA19988454301A patent/PA8454301A1/en unknown
- 1998-06-29 AR ARP980103146A patent/AR015917A1/en not_active Application Discontinuation
- 1998-06-29 UY UY25071A patent/UY25071A1/en not_active IP Right Cessation
- 1998-06-30 TN TNTNSN98124A patent/TNSN98124A1/en unknown
- 1998-06-30 ZA ZA9805708A patent/ZA985708B/en unknown
- 1998-06-30 MA MA25146A patent/MA24587A1/en unknown
- 1998-06-30 DZ DZ980158A patent/DZ2548A1/en active
- 1998-07-01 HR HR60/051,413A patent/HRP980377A2/en not_active Application Discontinuation
- 1998-07-01 HN HN1998000102A patent/HN1998000102A/en unknown
- 1998-07-01 CO CO98037137A patent/CO4940495A1/en unknown
-
1999
- 1999-11-19 IS IS5260A patent/IS5260A/en unknown
- 1999-11-23 BG BG103918A patent/BG103918A/en unknown
- 1999-12-21 OA OA9900301A patent/OA11243A/en unknown
- 1999-12-28 NO NO996520A patent/NO996520L/en not_active Application Discontinuation
-
2003
- 2003-06-19 AR ARP030102180A patent/AR040280A2/en unknown
- 2003-06-19 AR ARP030102179A patent/AR040279A2/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO4410315A1 (en) | ORAL COMPOSITION INCLUDING EFFECTIVE AMOUNT OF SODIUM SURFACE AND SODIUM LAURYL SULFOACETATE | |
ES2167453T3 (en) | MEDICINAL SUPPLY COMPOSITION CONTAINING CHITOSANE OR DERIVATIVE OF THE SAME WITH A POTENTIAL Z. DEFINED. | |
ATE80294T1 (en) | INJECTABLE, OPACIFYING LIPOSOME COMPOSITION. | |
ES2176684T3 (en) | NEW ASSOCIATIONS OF ACTIVE PRINCIPLES CONTAINING CLOPIDOGREL AND AN ANTHROMBOTIC. | |
ES2044156T3 (en) | TRANSPARENT SOAP CONTAINING 1,2-ALCANODIOL. | |
PE68899A1 (en) | COMPOSITION CONTAINING PARACETAMOL | |
AR040279A2 (en) | COMPOSITIONS CONTAINING SERTRALINE SALT | |
ES2182255T3 (en) | FLUORESCENT WHITENING AGENT. | |
MX9206150A (en) | ANTI-INFLAMMATORY AGENTS OF TRIPEPTIDE DERIVATIVES | |
ES2103483T3 (en) | LIQUID CLEANING COMPOSITIONS INCLUDING A PRIMARY ALKYL SULPHATE AND NON-IONIC SURFACTANTS. | |
ES2187489T3 (en) | DICLOFENAC BASED PHARMACEUTICAL COMPOSITIONS. | |
MX169821B (en) | CREAMY CLEANING COMPOCITIONS | |
ES2089613T3 (en) | DETERGENT COMPOSITION. | |
GB9122674D0 (en) | Toiletries composition | |
BR9810996A (en) | Pharmaceutical composition | |
ES2066578T3 (en) | CONCENTRATED LIQUID DETERGENT COMPOSITION CONTAINING A SEQUESTRATING AGENT OF THE POLYPHOSPHONATE TYPE. | |
KR960000200A (en) | Oral Composition | |
AR007059A1 (en) | USE OF INTERFERON IN THE PREPARATION OF MEDICINES AND COMPOSITIONS VIA OROMUCOSAL OR BY CONTACT | |
ES2139194T3 (en) | PERFUME COMPOSITION. | |
ES2149736T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING STABLE AND ANTIOXIDANT FREE THENOPyrIDINE DERIVATIVES. | |
BR9808577A (en) | Singlet oxygen generators having improved heavy atom effect. | |
MX169000B (en) | WATER BASED CLEANING COMPOSITION | |
ATE82102T1 (en) | DISINFECTANT. | |
MX168147B (en) | SHAMPOO COMPOSITIONS | |
ES2162036T3 (en) | ALKALINE DETERGENT WITH HIGH CONTENTS OF NON-IONIC TENSIANS AND COMPLEXING AGENT, AND USE OF AN ANOTHER COMPOUND AS A SOLUBIZER. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |